Skip to main content

Advertisement

Table 1 General information of pancreatic cancer patients (102 cases)

From: Vasohibin 2 reduces chemosensitivity to gemcitabine in pancreatic cancer cells via Jun proto-oncogene dependent transactivation of ribonucleotide reductase regulatory subunit M2

Category n (%)
Gender
 Male 40 (39.2)
 Female 62 (60.8)
Age (years)
 Average 61.5 ± 10.9
 Range 32-82
Chemotherapy (gemcitabine)
 Yes 30(29.4)
 No 72(70.6)
Pathology staging(AJCC 7th)
 I 10 (9.8)
 II 80 (78.5)
 III 12 (10.8)